PCG
2 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- 21-Hydroxylase Antibody (21-Ohab)
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.5660
- Medical specialty
- Immunology
- Flags
- Third-party review eligible
- FDA definition
- For semi-quantitative determination of antibodies to steroid 21-hydroxylase (21-OH) in human serum. The assay may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune Addison's disease (isolated) or Addison's disease as part of more complex autoimmune polyglandular syndrome (APS), type I or II. The assay result is to be used in conjunction with other clinical and laboratory findings and is not a substitute for functional testing required to diagnose adrenal insufficiency.
Download CSV table Client report (share link) ◉ Watch
Both buttons carry the same predicate table: the CSV downloads for your worksheet, the report is a shareable page for clients. Exports: 3 free/month with an account · reports & watching free.
Building a predicate table? Click + Add on candidates below (up to 8), then compare and export from your Builder.
| Record | Firm | Date | Builder |
|---|---|---|---|
| Steroid 21-Hydroxylase Antibody (21-OHAb) ELISA Kit (K180607) | Kronus, Inc. | 2018-11-23 | + Add |
| STEROID 21-HYDROXYLASE ANTIBODY (21-OHAB) RIA ASSAY KIT (K121046) | Kronus Market Development Associates, Inc. | 2012-12-20 | + Add |
Track PCG automatically
Every clearance here is in the API, with alerts when new ones post.